Nektar Therapeutics (NKTR)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Delivery

Drugs

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

30

0

0

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
22-Feb-24 8:16 PM View:	20-Feb-24 Sale ($13.62K)	Robin Howard W President & CEO Director		Nektar Therapeutics - NKTR	(2%) 900.33K to 880.3K	0	0	--	--	Show Txns Hide Txns

22-Feb-24 8:19 PM View:	20-Feb-24 Sale ($6.13K)	Zalevsky Jonathan Chief R&D Officer		Nektar Therapeutics - NKTR	(3%) 274.04K to 265.02K	0	0	--	--	Show Txns Hide Txns

22-Feb-24 8:17 PM View:	20-Feb-24 Sale ($5.17K)	Wilson Mark Andrew Chief Legal Officer		Nektar Therapeutics - NKTR	(3%) 244.28K to 236.67K	0	0	--	--	Show Txns Hide Txns